Eli Lilly and CoNYSE:LLY
Symbol Lookup
Refresh
Recent News»
0 New Today| Company | Market Cap | P/E Ratio (TTM) | EPS Growth (5yr) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | 57.0B | 74.8x | -30.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bristol-Myers Squibb Co BMY | 71.1B | 49.4x | +12.31% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Teva Pharmaceutical Industries Ltd TEVA | 37.5B | 18.0x | -0.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Baxter International Inc BAX | 39.5B | 17.6x | +9.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allergan Inc AGN | 30.1B | 27.1x | +17.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Data delayed 15 minutes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Information
Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health business segment. It manufactures and distributes its products through facilities in the United States, Puerto Rico, and 15 other countries. Its products are sold in approximately 130 countries. The Company's products include neuroscience products, endocrinology products, oncology products, cardiovascular products, animal health products and other pharmaceuticals. The Company's new molecular entities (NMEs), which are in Phase III clinical trial testing include Dulaglutide, Edivoxetine, Ixekizumab, Necitumumab, New insulin glargine product, Novel basal insulin analog, Pomaglumetad Methionil, Ramucirumab, Solanezumab and Tabalumab. In February 2012, the Company acquired ChemGen Corp. On July 7, 2011, it acquired the animal health business of Janssen, a Johnson & Johnson company.
| Headquarters | LILLY CORPORATE CENTER INDIANAPOLIS, IN, United States 46285 |
|---|---|
| Phone | 317-276-2000 |
| Fax | 317-276-3492 |
EXECUTIVE OFFICERS
| Acting Chairperson of the Board, Lead Independent Director | Ellen Marram |
|---|---|
| Acting Chief Executive Officer, Chief Financial Officer, Executive Vice President - Global Services | Derica Rice |
| President - Manufacturing Operations | Maria Crowe |
| Executive Vice President - Science and Technology, President - Lilly Research Laboratories | Jan Lundberg |
| Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer | Melissa Barnes |
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
Open a New Account, or Login if you're a client.
(GAAP)*
| Market Cap | $63.0B | Beta | 0.72 |
|---|---|---|---|
| Revenue (TTM) | $22.6B | EPS | $4.17 |
| Shares Out. | 1.1B | Book Value | $12.91 |
| Dividend Yield | 3.51% | P/E | 13.4x |
| Annual Dividend Rate | $1.96 | Price/Sales (TTM) | 2.8 |
| Ex-Div Date | 5/14/13 | P/Cash Flow (TTM) | 10.4x |
| Pay Date | 8/14/13 | Operating Margin | 26.65% |
*GAAP = prior to non-GAAP analyst adjusted earnings.
(Non-GAAP)*
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
